# Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-inflammatory-biomarkers-hiv/ > **Published:** 2026-03-26T10:03:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:24:21-04:00 > **Clinical Summary:** Explore cannabis use inflammatory biomarkers associations in people with HIV to understand potential impacts on immune activation and clinical care. --- CED Clinical Relevance  #72Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic HivInflammationBiomarkersCohortImmunology Journal Cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) Study Type Cohort Population Human participants Why This Matters People with HIV have exceptionally high rates of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) (up to 70% in some cohorts) alongside persistent immune activation despite viral suppression. Understanding whether [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) modulates inflammatory markers in this population could inform [clinical guidance](https://cedclinic.com/high-potency-thc-dosing-cannabis-flower-25-thc-safety/) for HIV care providers who routinely encounter patients using cannabis. Clinical Summary This cross-sectional analysis of 532 people with HIV examined associations between self-reported cannabis use patterns and 13 plasma inflammatory biomarkers. The study used data from seven academic HIV centers, focusing on patients with suppressed viral loads on antiretroviral therapy. Cannabis use was categorized as never, former, or current use within the past three months, with biomarker measurements occurring within one year of cannabis assessment. The analysis controlled for demographic factors and used sampling weights to adjust for cohort characteristics. Dr. Caplan’s Take “Without seeing the actual biomarker results, I cannot assess the clinical significance of any associations found. The study design appropriately focuses on virally suppressed patients, which eliminates a major confounding variable in HIV inflammation research.” Clinical Perspective 🧠 HIV clinicians should continue individualized discussions about cannabis use with their patients, acknowledging both potential benefits and risks. Until we have stronger evidence about cannabis effects on HIV-related inflammation, standard monitoring of immune markers and viral suppression remains the priority, regardless of cannabis use status. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Associations%20Between%20Cannabis%20Use%20and%20Inflammatory%20Biomarkers%20Among%20People%20with%20...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41883041/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41883041/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Associations%20Between%20Cannabis%20Use%20and%20Inflammatory%20Biomarkers%20Among%20People%20with%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41883041/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41883041/](https://pubmed.ncbi.nlm.nih.gov/41883041/) Table of Contents - [FAQ](#FAQ)[Does cannabis use affect inflammation levels in people with HIV?](#Does_cannabis_use_affect_inflammation_levels_in_people_with_HIV) - [Should I be concerned about cannabis use if I have HIV and am on treatment?](#Should_I_be_concerned_about_cannabis_use_if_I_have_HIV_and_am_on_treatment) - [How does chronic immune activation in HIV relate to cannabis use?](#How_does_chronic_immune_activation_in_HIV_relate_to_cannabis_use) - [What inflammatory markers were measured in this HIV cannabis study?](#What_inflammatory_markers_were_measured_in_this_HIV_cannabis_study) - [How reliable are the findings from this cannabis and HIV inflammation study?](#How_reliable_are_the_findings_from_this_cannabis_and_HIV_inflammation_study) - [Related](#Related) ## FAQ #### Does cannabis use affect inflammation levels in people with HIV? This study examined associations between cannabis use and inflammatory biomarkers in 532 people with HIV on antiretroviral therapy with viral suppression. The research measured 13 plasma biomarkers to assess whether current, former, or never cannabis use correlates with inflammatory markers in this population. #### Should I be concerned about cannabis use if I have HIV and am on treatment? If you have HIV with viral suppression on antiretroviral therapy, discuss cannabis use with your healthcare provider. This study contributes to understanding potential inflammatory effects, but individual medical decisions should always be made in consultation with your HIV specialist who knows your complete medical history. #### How does chronic immune activation in HIV relate to cannabis use? People with HIV often experience chronic immune activation and inflammation even when on effective treatment. This study investigated whether cannabis use might influence these inflammatory processes by measuring specific biomarkers in the blood of people with suppressed HIV. #### What inflammatory markers were measured in this HIV cannabis study? The researchers measured 13 different plasma biomarkers associated with inflammation in people with HIV. These biomarkers were analyzed to determine if there were measurable differences between people who never used cannabis, formerly used it, or were current users within the past 3 months. #### How reliable are the findings from this cannabis and HIV inflammation study? This study used data from seven major AIDS research centers and included 532 participants with well-controlled HIV, providing a substantial sample size. The researchers used standardized statistical methods and controlled for demographic factors, though as an observational study, it shows associations rather than proving causation. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41883041/”, “about”: “cannabis [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) cohort associations between”, “isPartOf”: “Cannabis and cannabinoid research”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Understanding the Effects of Cannabis on Inflammation – NUG Magazine](https://cedclinic.com/cannabinoid-mechanisms-action-inflammation/) An in-depth article exploring how cannabis influences inflammation and immune responses, providing context for clinical implications. [Read More](https://cedclinic.com/cannabinoid-mechanisms-action-inflammation/) [Cannabis use patterns and perception of acute pain during brief abstinence: sex-dependent associations with circulating cannabinoid levels.](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) Study examining cannabis use patterns and their biological effects, relevant to understanding biomarker variations in users. [Explore Study](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) The Science Behind Cannabis and Its Therapeutic Benefits – NUG Magazine Comprehensive review of cannabis therapeutic effects, supporting clinical perspectives on cannabis use in chronic conditions. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).